Sophie Kornowski-Bonnet

Sophie Kornowski-Bonnet currently works at Boston Pharmaceuticals, Inc., as Chairman & Chief Executive Officer from 2022, Corium LLC (Massachusetts), as Chairman, Syngenta AG, as Director from 2018, Syngenta Bangladesh Ltd., as Non-executive Director, Crossover Health, Inc., as Director, Même Cosmetics SAS, as Director from 2016, Mahana Therapeutics, Inc., as Director, Alladapt Immunotherapeutics, Inc., as Director, Teal Bio, Inc., as Director, Fairtility Ltd., as Director, BP Asset IX, Inc., as President & Director, and Gurnet Point Capital LLC, as Senior Partner from 2018.
Dr. Kornowski-Bonnet also formerly worked at Chugai Pharmaceutical Co., Ltd., as Director, Idorsia Ltd., as Non-Executive Director, and Ridoret Distribution SARL, as General Manager in 2012.
Dr. Kornowski-Bonnet received her Masters Business Admin degree from The University of Chicago and doctorate degree from Université de Paris 5 René Descartes.